DK0527753T4 - Oprensning af et pertussis ydre membran-protein - Google Patents

Oprensning af et pertussis ydre membran-protein

Info

Publication number: DK0527753T4
Authority: DK; Denmark
Prior art keywords: pertussis; purified; purification; component; membrane protein
Prior art date: 1990-04-04

Application number

DK91906730T

Other languages

English (en)

Other versions

DK0527753T3 (da

Inventor

Pele Chong

Michel Klein

Raafat Fahim

Gail Jackson

Larry Tan

John Vose

Original Assignee

Connaught Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-04-04

Filing date

1991-04-03

Publication date

2004-03-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10673904&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0527753(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-04-03 Application filed by Connaught Lab filed Critical Connaught Lab

1997-04-07 Publication of DK0527753T3 publication Critical patent/DK0527753T3/da

2004-03-22 Application granted granted Critical

2004-03-22 Publication of DK0527753T4 publication Critical patent/DK0527753T4/da

Links

101710116435 Outer membrane protein Proteins 0.000 title 1
201000005702 Pertussis Diseases 0.000 title 1
238000000746 purification Methods 0.000 title 1
241000588832 Bordetella pertussis Species 0.000 abstract 2
108010081690 Pertussis Toxin Proteins 0.000 abstract 2
239000000427 antigen Substances 0.000 abstract 2
102000036639 antigens Human genes 0.000 abstract 2
108091007433 antigens Proteins 0.000 abstract 2
241000588807 Bordetella Species 0.000 abstract 1
102000030621 adenylate cyclase Human genes 0.000 abstract 1
108060000200 adenylate cyclase Proteins 0.000 abstract 1
229960003983 diphtheria toxoid Drugs 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
108010021711 pertactin Proteins 0.000 abstract 1
229960000814 tetanus toxoid Drugs 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Oncology (AREA)
Veterinary Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK91906730T 1990-04-04 1991-04-03 Oprensning af et pertussis ydre membran-protein DK0527753T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB909007657A GB9007657D0 (en)	1990-04-04	1990-04-04	Purification of a pertussis outer membrane protein(omp69)
PCT/CA1991/000110 WO1991015505A1 (en)	1990-04-04	1991-04-03	Purification of a pertussis outer membrane protein

Publications (2)

Publication Number	Publication Date
DK0527753T3 DK0527753T3 (da)	1997-04-07
DK0527753T4 true DK0527753T4 (da)	2004-03-22

Family

ID=10673904

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91906730T DK0527753T4 (da)	1990-04-04	1991-04-03	Oprensning af et pertussis ydre membran-protein

Country Status (11)

Country	Link
US (2)	US5444159A (da)
EP (2)	EP0527753B2 (da)
JP (1)	JP2549225B2 (da)
AT (1)	ATE147754T1 (da)
CA (1)	CA2079887C (da)
DE (3)	DE761230T1 (da)
DK (1)	DK0527753T4 (da)
ES (2)	ES2088374T5 (da)
GB (1)	GB9007657D0 (da)
GR (2)	GR3022769T3 (da)
WO (1)	WO1991015505A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8412207D0 (en) *	1984-05-12	1984-06-20	Wellcome Found	Antigenic preparations
GB8910570D0 (en)	1989-05-08	1989-06-21	Wellcome Found	Acellular vaccine
US6197548B1 (en)	1990-04-02	2001-03-06	Medeva Pharma Limited	Transformed Pichia expressing the pertactin antigen
NL9002092A (nl) *	1990-09-25	1992-04-16	Nederlanden Staat	Vaccin, geschikt voor de bestrijding van bordetella pertussis.
US6444211B2 (en) *	1991-04-03	2002-09-03	Connaught Laboratories, Inc.	Purification of a pertussis outer membrane protein
GB9304399D0 (en) *	1993-03-04	1993-04-21	Smithkline Beecham Biolog	Novel process
DE69511392T2 (de) *	1994-04-28	2000-03-23	Takeda Chemical Industries Ltd	Verfahren zur trennung von protektiven verbindungen aus bordetella pertussis
US5877298A (en) *	1995-05-04	1999-03-02	Connaught Lab	Acellular pertussis vaccines and methods of preparing thereof
EP1233022B1 (en) *	1995-05-04	2015-12-09	Aventis Pasteur Limited	Methods of preparation of components of acellular pertussis vaccines
JP3745805B2 (ja) *	1995-10-24	2006-02-15	日本ケミカルリサーチ株式会社	トロンボモジュリンの精製方法
US5739313A (en)	1995-11-13	1998-04-14	Regents Of The University Of Minnesota	Radionuclide labeling of vitamin B12 and coenzymes thereof
AU724743B2 (en) *	1996-05-31	2000-09-28	Genetics Institute, Llc	IL-12 as an adjuvant for Bordetella Pertussis vaccines
EP1762246A1 (en)	1996-07-02	2007-03-14	Sanofi Pasteur Limited	Multivalent DTP-Polio vaccines
DE60231651D1 (de) *	2001-12-21	2009-04-30	Immunex Corp	Proteinreinigungsverfahren
WO2009016651A1 (en) *	2007-07-31	2009-02-05	Panacea Biotec Limited	Simplified means for obtaining prn from bordetella pertussis
US8574589B2 (en)	2009-05-11	2013-11-05	Novartis Ag	Antigen purification process for pertactin antigen
CN102584958A (zh) *	2012-02-08	2012-07-18	北京天坛生物制品股份有限公司	百日咳杆菌69kd外膜蛋白的纯化方法
DK2863943T3 (da)	2013-03-08	2016-11-07	Janssen Vaccines & Prevention Bv	Acellulær pertussisvaccine
KR102426041B1 (ko) *	2017-08-01	2022-07-29	주식회사 녹십자	냉동 및 해동 과정을 포함하는 백일해균 유래 단백질 수득 방법
CN113151081A (zh) *	2021-04-21	2021-07-23	深圳市儿童医院	一种百日咳鲍特菌培养基及其制备方法
WO2024056508A1 (en)	2022-09-15	2024-03-21	Cube Biotech Gmbh	In vitro diagnostic method for detecting the presence of a target by using stabilized membrane proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5237052A (en) *	1984-05-12	1993-08-17	Burroughs Wellcome Company	Antigenic preparations and isolation of such preparations
GB8412207D0 (en) *	1984-05-12	1984-06-20	Wellcome Found	Antigenic preparations
GB8807860D0 (en) *	1988-04-05	1988-05-05	Connaught Lab	Pertussis vaccine
US5101014A (en) *	1989-02-10	1992-03-31	United States Of America	Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis
US5276142A (en) *	1989-12-11	1994-01-04	American Cyanamid Company	Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
GB9007416D0 (en) †	1990-04-02	1990-05-30	Wellcome Found	Expression of heterologous protein in yeast

1990
- 1990-04-04 GB GB909007657A patent/GB9007657D0/en active Pending
1991
- 1991-04-03 EP EP91906730A patent/EP0527753B2/en not_active Expired - Lifetime
- 1991-04-03 JP JP3506712A patent/JP2549225B2/ja not_active Expired - Lifetime
- 1991-04-03 DE DE0761230T patent/DE761230T1/de active Pending
- 1991-04-03 WO PCT/CA1991/000110 patent/WO1991015505A1/en active IP Right Grant
- 1991-04-03 DE DE69124235T patent/DE69124235T3/de not_active Expired - Lifetime
- 1991-04-03 EP EP96202627A patent/EP0761230A3/en not_active Withdrawn
- 1991-04-03 DE DE0527753T patent/DE527753T1/de active Pending
- 1991-04-03 CA CA002079887A patent/CA2079887C/en not_active Expired - Lifetime
- 1991-04-03 AT AT91906730T patent/ATE147754T1/de not_active IP Right Cessation
- 1991-04-03 ES ES91906730T patent/ES2088374T5/es not_active Expired - Lifetime
- 1991-04-03 DK DK91906730T patent/DK0527753T4/da active
- 1991-04-03 ES ES96202627T patent/ES2104535T1/es active Pending
1992
- 1992-11-06 US US07/930,595 patent/US5444159A/en not_active Expired - Lifetime
1995
- 1995-05-04 US US08/433,644 patent/US5667787A/en not_active Expired - Lifetime
1997
- 1997-03-07 GR GR970400453T patent/GR3022769T3/el unknown
- 1997-10-31 GR GR970300034T patent/GR970300034T1/el unknown

Also Published As

Publication number	Publication date
ES2088374T3 (es)	1997-05-16
ES2104535T1 (es)	1997-10-16
ATE147754T1 (de)	1997-02-15
CA2079887C (en)	1998-06-23
EP0527753B1 (en)	1997-01-15
ES2088374T1 (es)	1996-08-16
DE761230T1 (de)	1997-09-25
US5667787A (en)	1997-09-16
ES2088374T5 (es)	2004-08-16
JPH05506649A (ja)	1993-09-30
GB9007657D0 (en)	1990-05-30
GR3022769T3 (en)	1997-06-30
DE69124235D1 (de)	1997-02-27
EP0527753B2 (en)	2003-12-17
DK0527753T3 (da)	1997-04-07
DE69124235T2 (de)	1997-05-28
DE69124235T3 (de)	2004-06-03
GR970300034T1 (en)	1997-10-31
WO1991015505A1 (en)	1991-10-17
EP0527753A1 (en)	1993-02-24
US5444159A (en)	1995-08-22
DE527753T1 (de)	1996-11-28
JP2549225B2 (ja)	1996-10-30
EP0761230A2 (en)	1997-03-12
EP0761230A3 (en)	1999-01-20
CA2079887A1 (en)	1991-10-05

Publication	Publication Date	Title
DK0527753T4 (da)	2004-03-22	Oprensning af et pertussis ydre membran-protein
LU91591I2 (fr)	2009-10-12	Combinaison d'antoxine diphtérique, d'anatoxine tétanique,d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine, d'agglutinogènes fimbriaux coquelucheux 2 et 3 et de virus poliomyélitique inactivé type1, type 2 et type 3 (Triaxis Polio)
LU90203I2 (fr)	1998-04-06	Anatoxine diphtérique anatoxine tétanique trois antigènes coquelucheux purifiés (toxine pertussique tp hémagglutinine filamenteuse (haf) et pertactine (protéine de membrane externe 69 kd) et le principal antigène de surface du virus de l'hépatite b (vhb) purfié (infanrix hepb) et ses dérivés pharmaceutiquement acceptables
ATE128628T1 (de)	1995-10-15	Faser-hemagglutinin von bordetella pertussis als träger für konjugierten impfstoff.
LU93036I2 (fr)	2016-06-21	Vaccin diphtérirque, tétanique, coquelucheux (composant acelluaire, et incluant fimbriae des types 2 et 3), de l'hépatite b (adnr), poliomyélitique (inactivé), et conjugué de l'haemophilus de type b (adsrobé)
KR920002790A (ko)	1992-02-28	보르데텔라 퍼투스시스에 의해 발병되는 질병을 예방하는데 유효한 백신 및 비백일해 백신 성분과 조합된 상기 백신으로 구성되는 다가성 백신
BR9712917A (pt)	1999-12-07	Vacina pertussis acelular com toxóides diftérico e tetânico
DE69113991D1 (de)	1995-11-23	Impfstoff.
AU635083B2 (en)	1993-03-11	Purification of b.pertussis toxin and filamentous hemagglutinin antigen
FR2736064B1 (fr)	1997-09-05	Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella
GB9611501D0 (en)	1996-08-07	Vaccine compositions
DE3889975D1 (de)	1994-07-14	Bordetella pertussis-Varianten.
Bhandari et al.	1990	Testing of adsorbed diphtheria-pertussis-tetanus (DPT) vaccine for freedom from abnormal toxicity